Quantitative phase imaging of platelet: assessment of cell morphology and function
暂无分享,去创建一个
Vladislav Metelin | Irina Vasilenko | Elizaveta Vlasova | B. Agadzhanjan | R. Lyfenko | I. Vasilenko | V. Metelin | E. Vlasova | B. Agadzhanjan | R. Lyfenko
[1] T. V. D. van de Ven,et al. Long-range interactions in mammalian platelet aggregation. II. The role of platelet pseudopod number and length. , 1990, Biophysical journal.
[2] M. Hino,et al. Clinical significance of simultaneous measurement of reticulated platelets and large platelets in idiopathic thrombocytopenic purpura. , 2000, Haematologia.
[3] B. Suess,et al. Pharmacological Inhibition of Platelet-Tumor Cell Cross-Talk Prevents Platelet-Induced Overexpression of Cyclooxygenase-2 in HT29 Human Colon Carcinoma Cells , 2013, Molecular Pharmacology.
[4] R. Abbate,et al. Platelet function tests: a comparative review , 2015, Vascular health and risk management.
[5] S. Choi,et al. Mean platelet volume in Korean patients with acute ischemic stroke: A gender difference , 2013, Platelets.
[6] V. P. Tychinskii,et al. Coherent phase microscopy of intracellular processes , 2001 .
[7] R. Hynes,et al. Abstract PR1: Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis , 2011 .
[8] Cynthia S. Johnson,et al. Prognostic factors in stage III non-small-cell lung cancer. , 2007, Clinical Lung Cancer.
[9] John F. Martin,et al. A role for changes in platelet production in the cause of acute coronary syndromes. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[10] S. Watson. Platelet activation by extracellular matrix proteins in haemostasis and thrombosis. , 2009, Current pharmaceutical design.
[11] Laurie J. Gay,et al. Contribution of platelets to tumour metastasis , 2011, Nature Reviews Cancer.
[12] G. Lip,et al. The effects of coronary artery disease severity on time-dependent changes in platelet activation indices in stored whole blood , 2008, Journal of Thrombosis and Thrombolysis.
[13] M. Lishner,et al. Are platelet volume indices of clinical use? A multidisciplinary review , 2012, Annals of medicine.
[14] P. Noris,et al. Platelet size distinguishes between inherited macrothrombocytopenias and immune thrombocytopenia , 2009, Journal of thrombosis and haemostasis : JTH.
[15] Heesang Song,et al. Mean platelet volume: a potential biomarker of the risk and prognosis of heart disease , 2016, The Korean journal of internal medicine.
[16] Deepak L. Bhatt,et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta‐analysis , 2010, Journal of thrombosis and haemostasis : JTH.
[17] E. Abel,et al. Mean platelet volume is a useful parameter: a reproducible routine method using a modified Coulter thrombocytometer. , 2000, Platelets.
[18] K. Jurk,et al. Platelets: Physiology and Biochemistry , 2005, Seminars in thrombosis and hemostasis.
[19] O. Guntinas-Lichius,et al. Prognostic impact of pretherapeutic laboratory values in head and neck cancer patients , 2012, Journal of Cancer Research and Clinical Oncology.
[20] M. Rusak,et al. Platelet activation in patients with advanced gastric cancer. , 2010, Neoplasma.
[21] G. Kitas,et al. Mean platelet volume: a link between thrombosis and inflammation? , 2011, Current pharmaceutical design.
[22] Marianne Paesmans,et al. Prognostic factors in stage III non-small cell lung cancer: a review of conventional, metabolic and new biological variables , 2011, Therapeutic advances in medical oncology.
[23] S. Goodman,et al. Platelet interaction with pyrolytic carbon heart-valve leaflets. , 1996, Journal of biomedical materials research.
[24] G. FitzGerald,et al. Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells , 2016, Oncotarget.